Biotech

Microbot Medical Reports Data from its GLP Pivotal Pre-Clinical Study

Microbot Medical Reports Data from its GLP Pivotal Pre-Clinical Study

Shots: Microbot Medical concludes its pivotal GLP pre-clinical study in porcine mo...

Daiichi Sankyo Entered into a Development and Commercialization Agreement with Merck for Three Daiichi Sankyo DXd ADCs

Daiichi Sankyo Entered into a Development and Commercialization Agreement with Merck for Three Daiichi Sankyo DXd ADCs

Shots: Daiichi Sankyo will receive $4B up front ($1.5B for ifinatamab deruxtecan d...

Monte Rosa Therapeutics Collaborated with Roche to Discover Novel Molecular Glue Degraders Targeting Cancer and Neurological Diseases

Monte Rosa Therapeutics Collaborated with Roche to Discover Novel Molecular Glue Degraders Targeting Cancer and Neurological Disea...

Shots: Monte Rosa Therapeutics will receive $50M up front and is eligible to recei...

SpliceBio Signs an Exclusive Collaboration and License Agreement with Spark Therapeutics to Develop Gene Therapy

SpliceBio Signs an Exclusive Collaboration and License Agreement with Spark Therapeutics to Develop Gene Therapy

Shots: SpliceBio will be eligible to receive up front, opt-in, and milestones of ~...

SOTIO Entered into a License Agreement with Synaffix to Expand ADC Pipeline

SOTIO Entered into a License Agreement with Synaffix to Expand ADC Pipeline

Shots: Synaffix will receive ~$740M incl. signature, target nomination & miles...

MediLink Therapeutics Entered into a Collaboration and License Agreement with BioNTech to Develop Next-Generation Anti-Cancer Antibody-Drug Conjugate

MediLink Therapeutics Entered into a Collaboration and License Agreement with BioNTech to Develop Next-Generation Anti-Cancer Anti...

Shots: MediLink will receive $70M up front and is eligible to receive additional d...

Image